Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Mallinckrodt
Farmers Insurance
McKinsey
Cipla
Queensland Health
Johnson and Johnson
Boehringer Ingelheim
Julphar

Generated: February 22, 2018

DrugPatentWatch Database Preview

ORPHENADRINE CITRATE Drug Profile

« Back to Dashboard

Which patents cover Orphenadrine Citrate, and what generic alternatives are available?

Orphenadrine Citrate is a drug marketed by Akorn, Sagent Pharms, Watson Labs, West-ward Pharms Int, Ascot, Gavis Pharms, Impax Pharms, Invagen Pharms, Sandoz, Tedor Pharma Inc, and Stevens J. and is included in fifteen NDAs.

The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Drug patent expirations by year for ORPHENADRINE CITRATE
Pharmacology for ORPHENADRINE CITRATE

US Patents and Regulatory Information for ORPHENADRINE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 040484-001 May 24, 2006 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gavis Pharms ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040284-001 Jun 19, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 087062-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tedor Pharma Inc ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040249-001 Jan 29, 1999 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Pharms ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040368-001 Jun 23, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Stevens J ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074988-001 Apr 30, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074654-001 Dec 31, 1996 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 090585-001 Aug 30, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 084779-001 Mar 15, 1982 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ascot ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 088067-001 Apr 6, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Julphar
Moodys
Chubb
Citi
Dow
Daiichi Sankyo
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot